↓ Skip to main content
What is this page? Embed badge

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study

Overview of attention for article published in Schizophrenia Research, January 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy
2 policy sources
guideline
1 clinical guideline source

Readers on

mendeley
82 Mendeley
So far, Altmetric has seen 3 Guidelines that reference this research output.

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

Clinical guideline published by British Association for Psychopharmacology (BAP) on

The British Association for Psychopharmacology (BAP) focuses on advancing the field of psychopharmacology through evidence-based guidelines and consensus statements. They provide resources for professionals, including guidelines on various mental health topics, enhancing clinical decision-making.

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Clinical guideline published by British Association for Psychopharmacology (BAP) on

The British Association for Psychopharmacology (BAP) focuses on advancing the field of psychopharmacology through evidence-based guidelines and consensus statements. They provide resources for professionals, including guidelines on various mental health topics, enhancing clinical decision-making.

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

Clinical guideline published by British Association for Psychopharmacology (BAP) on

The British Association for Psychopharmacology (BAP) focuses on advancing the field of psychopharmacology through evidence-based guidelines and consensus statements. They provide resources for professionals, including guidelines on various mental health topics, enhancing clinical decision-making.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.